Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Clinical Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- South Med J1
Search Results
Sort by
- Bookedited by Pedro Merino.Contents:
Deoxynucleoside analogues / Vicente Gotor
Nucleosides modified at the base moiety / Luigi Agrofoglio
Acyclic nucleosides / Antonin Holy
Phosphorylated nucleoside analogues / Giovanni Romeo
Triphosphorylated nucleoside analogues / Chris Meier
Pro-nucleotides / Christian Perigaud
C-nucleoside / Sergio Castillón
Isonucleosides / Vasu Nair
Conformationally constrained nucleosides / Jacques Lebreton
Spironucleosides / Maria Jose Camarasa
L-nucleosides / Daniela Perrone
Carbocyclic nucleosides / Eric Leclerc
Uncommon three-, four, and six-membered nucleosides / Elisabetta Groaz
Thionucleosides / L.S. Jeong
Azanucleosides and related compounds / Tomas Tejero
Oxathiolane and dioxolane nucleosides / Annalisa Guaragna
Isoxazolidinyl nucleosides / Ugo Chiacchio
Nucleoside antibiotics / Apurba Dutta
Building blocks for peptide nucleic acids / Pedro Merino.Digital Access Wiley 2013 - ArticleSmith EB, Graham JL, Ulrich JA.South Med J. 1977 Jan;70(1):47-8.Clotrimazole is a new antifungal agent which is effective topically in dermatophytosis, cutaneous candidiasis, and tinea vesicolor. The authors performed a controlled double-blind clinical trial comparing topical clotrimazole with its vehicle in the treatment of 66 patients with dermatophytic infections of the skin of the feet. Clotrimazole proved to be effective in the treatment of tinea pedis of both the interdigital and the plantar hyperkeratotic types.